ClinicalTrials.govpublic full text
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
egfr gene mutation, lung cancer, lung cancer metastatic, egfr c797s, egfr mutant lung cancer, dacomitinib, osimertinib, 18-341, memorial sloan kettering cancer center, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 914034
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.